Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:38 pm Purchase | 2025-10-31 | 13G | Cybin Inc. CYBN | Venrock Healthcare Capital Partners III, L.P. | 5,111,412 9.900% | 5,111,412 (New Position) | Filing History |
| 2025-09-25 8:34 pm Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | Venrock Healthcare Capital Partners III, L.P. | 760,699 9.900% | 760,699 (New Position) | Filing History |
| 2025-08-14 5:59 pm Sale | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 639,088 3.200% | -459,908 (-41.85%) | Filing History |
| 2025-08-14 5:58 pm Sale | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 1,000,000 3.100% | -744,373 (-42.67%) | Filing History |
| 2025-08-14 5:56 pm Sale | 2025-06-30 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III, L.P. | 2,047,620 3.800% | -1,347,986 (-39.70%) | Filing History |
| 2025-08-14 5:55 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 449,492 9.900% | 31,951 (+7.65%) | Filing History |
| 2025-08-14 5:52 pm Sale | 2025-06-30 | 13G | Zura Bio Limited ZURA | Venrock Healthcare Capital Partners III, L.P. | 6,353,353 9.900% | -677,918 (-9.64%) | Filing History |
| 2025-07-08 5:31 pm Purchase | 2025-06-30 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners III, L.P. | 9,021,507 5.200% | 9,021,507 (New Position) | Filing History |
| 2025-06-23 4:30 pm Purchase | 2025-06-13 | 13G | Crescent Biopharma, Inc. CBIO | Venrock Healthcare Capital Partners III, L.P. | 1,391,196 9.900% | 1,391,196 (New Position) | Filing History |
| 2025-05-30 4:35 pm Purchase | 2025-04-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 6,596,885 7.700% | 3,414,358 (+107.28%) | Filing History |
| 2025-05-20 4:25 pm Purchase | 2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | Venrock Healthcare Capital Partners III, L.P. | 12,992,500 8.200% | 12,992,500 (New Position) | Filing History |
| 2025-05-15 5:48 pm Sale | 2025-03-31 | 13G | Mersana Therapeutics, Inc. MRSN | Venrock Healthcare Capital Partners III, L.P. | 142,973 2.900% | -267,339 (-65.16%) | Filing History |
| 2025-05-15 5:47 pm Sale | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 1,098,996 9.900% | -30,101 (-2.67%) | Filing History |
| 2025-05-15 5:47 pm Sale | 2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 3,182,527 4.500% | -1,245,858 (-28.13%) | Filing History |
| 2025-05-15 5:46 pm Sale | 2025-03-31 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 5,567,709 4.100% | -6,237,592 (-52.84%) | Filing History |
| 2025-05-15 5:45 pm Sale | 2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 1,016,497 4.900% | -173,843 (-14.60%) | Filing History |
| 2025-05-15 5:44 pm Purchase | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 417,541 9.900% | 417,541 (New Position) | Filing History |
| 2025-05-15 5:44 pm Sale | 2025-03-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Venrock Healthcare Capital Partners III, L.P. | 677,600 1.500% | -2,274,771 (-77.05%) | Filing History |
| 2025-05-15 5:43 pm Purchase | 2025-03-31 | 13G | Zura Bio Limited ZURA | Venrock Healthcare Capital Partners III, L.P. | 7,031,271 9.900% | 177,671 (+2.59%) | Filing History |
| 2025-05-05 4:26 pm Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | Venrock Healthcare Capital Partners III, L.P. | 3,220,369 9.900% | 3,220,369 (New Position) | Filing History |